Abstract
BackgroundPD-1 inhibitor have demonstrated significant efficacy in the treatment of recurrent or refractory gynecologic cancer. However, the clinical data among Chinese patients is still limited. In this study, the efficacy...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
